25.10.2012
- French drugmaker Sanofi forecast 2012 earnings would fall less than expected as cost cuts and demand for diabetes and rare disease drugs cushion the blow from patent expiries...
24.10.2012
- Amgen on Tuesday reported higher-than-expected third-quarter profit in its first full quarter under Chief Executive Robert Bradway and it raised its full-year earnings and revenue...
24.10.2012
- Fujifilm Diosynth Biotechnologies has announced it has entered into a strategic alliance with Piramal Healthcare UK, whereby the two parties will offer the seamless contract...
18.10.2012
- U.S. health regulators have approved ThromboGenics's main drug, eye treatment Jetrea, clearing the way for the Belgian biotechnology company to make sustainable profits...
18.10.2012
- Hopes for a key new heart and lung drug overshadowed nine-month results from Actelion, which showed a modest 4% slide in sales of the Swiss group's current mainstay Tracleer...
15.10.2012
- Biotech company ExpreS2ion Biotechnologies today announced that they have signed a research license agreement to provide the University of Oxford access to ExpreS2ion's Drosophila...
13.10.2012
- Applikon Biotechnology, a private Dutch company specialized in the development, manufacture and supply of bioreactor systems for both research and production use, has started the...
09.10.2012
- Evonik Industries, a manufacturers of specialty chemicals, plans to continue expanding its commitment to biotechnology. "Biotech opens up interesting opportunities for profitable...
06.10.2012
- The Obama administration's reluctance to push for 12 years of data protection on "biologic" medicines in free-trade talks is a growing concern for U.S. drug manufacturers who...
04.10.2012
- From its base in a business park outside the city of Ghent, Belgium's biotech industry is attracting a global following, benefiting from years of patient investment, promising...
